145 related articles for article (PubMed ID: 8518234)
1. Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells.
Donato NJ; Yan DH; Hung MC; Rosenblum MG
Cell Growth Differ; 1993 May; 4(5):411-9. PubMed ID: 8518234
[TBL] [Abstract][Full Text] [Related]
2. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.
Nishikawa K; Rosenblum MG; Newman RA; Pandita TK; Hittelman WN; Donato NJ
Cancer Res; 1992 Sep; 52(17):4758-65. PubMed ID: 1380890
[TBL] [Abstract][Full Text] [Related]
3. Positive and negative selection for tumor necrosis factor responsiveness reveals an inhibitory role for EGF receptor in TNF-induced antiproliferation.
Nishikawa K; Rotbein J; Vijjeswarapu D; Owen-Schaub L; Rosenblum MG; Donato NJ
Lymphokine Cytokine Res; 1994 Feb; 13(1):37-45. PubMed ID: 8186323
[TBL] [Abstract][Full Text] [Related]
4. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
Donato NJ; Ince C; Rosenblum MG; Gallick GE
J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
[TBL] [Abstract][Full Text] [Related]
5. EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.
Donato NJ; Perez M; Kang H; Siddik ZH; Ling YH; Perez-Soler R
Clin Cancer Res; 2000 Jan; 6(1):193-202. PubMed ID: 10656450
[TBL] [Abstract][Full Text] [Related]
6. Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: potential interaction with epidermal growth factor receptor.
Perez M; Haschke B; Donato NJ
Oncogene; 1999 Jan; 18(4):967-78. PubMed ID: 10023672
[TBL] [Abstract][Full Text] [Related]
7. Activation of epidermal growth factor receptor tyrosine phosphorylation by tumor necrosis factor correlates with loss of cytotoxic activity.
Perez M; Donato NJ
J Interferon Cytokine Res; 1996 Apr; 16(4):307-14. PubMed ID: 9162524
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.
Donato NJ; Rosenblum MG; Steck PA
Cell Growth Differ; 1992 May; 3(5):259-68. PubMed ID: 1378752
[TBL] [Abstract][Full Text] [Related]
9. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
Ahmad F; Goldstein BJ
J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity mediated by tumor necrosis factor in variant subclones of the ME-180 cervical carcinoma line: modulation by specific inhibitors of DNA topoisomerase II.
Coffman FD; Green LM; Godwin A; Ware CF
J Cell Biochem; 1989 Feb; 39(2):95-105. PubMed ID: 2541144
[TBL] [Abstract][Full Text] [Related]
11. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
Sartor CI; Dziubinski ML; Yu CL; Jove R; Ethier SP
Cancer Res; 1997 Mar; 57(5):978-87. PubMed ID: 9041204
[TBL] [Abstract][Full Text] [Related]
12. Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells.
Fujii K; Furukawa F; Matsuyoshi N
Exp Cell Res; 1996 Feb; 223(1):50-62. PubMed ID: 8635495
[TBL] [Abstract][Full Text] [Related]
13. Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells.
Kim JS; Steck PA; Gallick GE; Lee JS; Blick M; Hong WK; Lotan R
J Natl Cancer Inst Monogr; 1992; (13):101-10. PubMed ID: 1389683
[TBL] [Abstract][Full Text] [Related]
14. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells.
Mawatari M; Kohno K; Mizoguchi H; Matsuda T; Asoh K; Van Damme J; Welgus HG; Kuwano M
J Immunol; 1989 Sep; 143(5):1619-27. PubMed ID: 2547871
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors.
Mishra S; Mathur R; Hamburger AW
Lymphokine Cytokine Res; 1994 Apr; 13(2):77-83. PubMed ID: 8061118
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
17. Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431.
Meuillet EJ; Kroes R; Yamamoto H; Warner TG; Ferrari J; Mania-Farnell B; George D; Rebbaa A; Moskal JR; Bremer EG
Cancer Res; 1999 Jan; 59(1):234-40. PubMed ID: 9892212
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor gene expression, protein kinase activity, and terminal differentiation of human malignant epidermal cells.
King I; Sartorelli AC
Cancer Res; 1989 Oct; 49(20):5677-81. PubMed ID: 2790786
[TBL] [Abstract][Full Text] [Related]
19. Modulation of EGF receptor by tumor necrosis factor-alpha in human hepatocellular carcinoma HepG2 cells.
Wang D; Yang EB; Cheng LY
Anticancer Res; 1996; 16(5A):3001-6. PubMed ID: 8917420
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity.
Donato NJ; Gallick GE; Steck PA; Rosenblum MG
J Biol Chem; 1989 Dec; 264(34):20474-81. PubMed ID: 2555361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
